| Prev Close | 2.48 |
| Open | 2.49 |
| Day Low/High | 2.42 / 2.52 |
| 52 Wk Low/High | 2.14 / 10.32 |
| Volume | 12.95M |
| Avg Volume | 21.93M |
Aurora Cannabis Inc. (ACB)
2.44
0.04
1.40
NYSE : Process Industries
| Exchange | NYSE |
| Shares Outstanding | 1.05B |
| Market Cap | 2.58B |
| EPS | -0.20 |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Latest News
3 Stocks for Traders to Watch Now
It's been a strange week. Here's some guidance.
Fool Me Twice Shame on Me (Part Deux)
* I continue to trade opportunistically and unemotionally - with a calculator in one hand and a contrarian viewpoint on the other hand * The overnight +20 futures rise (China trade-related) has been reversed to a gain of only 3 handles by 6: 30 am *...
Thick Skin for These Markets, Saudi Aramco IPO, Trading Zscaler: Market Recon
A market repricing...which are the 'true' growth stocks now?
I'm Watching These 3 Stocks on Friday
Snap, Aurora Cannabis and Cars.com have caught my attention.
Earnings to Tell Whether Cannabis' High Growth Story Is Going to Pot
After a 2018 high, marijuana stocks are gaining popularity again, but which ones are producing the most green for investors? Here are the charts.
Tilray Stock Gains Ahead of Highly Anticipated Earnings Release
Tilray will look to sustain a sanguine sentiment on cannabis stocks on Tuesday.
Aphria and Aurora Cannabis: Smoking Out the Differences for Investors
Aurora is trying to ride the momentum of Aphria's earnings report and jump in front of other potential strong reports.
Not Up In Smoke!
Yesterday and most of last week I have been expanding my Canopy Growth long investment position (the stock is on my Best Ideas List). CGC (+6%) and the other pot stocks should thrive today after the Aurora Cannabis revised upward guidance (its share...
Morningstar High on Pot Growth, Sees U.S. Going Legal by 2023
Analysts say nation will turn a new leaf, changing federal law within a few years, as cannabis industry expected to grow big time over next decade.
5 Cannabis ETFs to Fire Up Your Portfolio
Two of them are brand new.
Prohibition and the Paradoxical Proclivity of Cannabis Consumption
Is prohibition the real factor propping up projections for demand and pricing in the cannabis market?
Canopy Growth Slips as Production, Margins Disappoint
While the cannabis company's stock is sliding on its year-end report, at least one analyst sees a long-term buying opportunity.
I'm a Net Seller in the Market Today
Overall, I don't like the action I'm seeing on my screens. I've been a heavy net seller as I cut positions that are showing some relative weakness.
Canopy Growth Now Has to be Considered the Leader in the Canadian Cannabis Space
CGC has the best chance to transition to broader success should the U.S. ever go the route of legalization beyond the state level.
Checking on Aurora Cannabis
I just mentioned one of my partners here at TheStreet, now let's wheel about and mention 'Sarge' Guilfoyle who sat in this very seat yesterday. In the Stocks Under $10 portfolio, he's been the man in charge of the weed stocks positions and he's done...
Up In Smoke?
The pot sector has been weak recently. I own a very small long position in which is -$1 to under $44/share (which was added to my Best Ideas List on January 2, 2019 at $27.75) As I mentioned I wasn't willing to pay up for recently and, in general, ...
Cronos Group Certainly Qualifies for Mainstream Consideration
Revenue is where it's at for cannabis in 2019.
2 Big Earnings Reports I'll Be Watching This Week
A huge week is coming up for these well-known stocks.
With Tilray, You Won't Win Any Valuation Arguments
Short interest is back in the low single digits while Tilray still enjoys one of the smallest floats for a cannabis company.
Tilray Is Not My Favorite Canadian Cannabis Stock
Apparently, this game is all about growth right now. It certainly is not about margins.
Look Out for an Intraday Reversal in the Market
Some momentum movers are becoming extended and have seen profit-taking Monday.
Don't Miss Out on the Trading Action
If you dig a little deeper there is some very positive action.
I Would Not Pay Up For Aurora Cannabis (Part Deux)
On Wednesday I explained why I would not buy the gap higher in Aurora Cannabis . There is a tendency for traders, in particular, to buy the latest shiny object and to ask questions later; after all the price momentum is a tradeable thing of beauty t...
Chart of the Day: Vetting the Value of Cannabis Companies
Assessing Aurora and its peers, strictly on the numbers.
Jim Cramer: AAPL Should Get Into Diabetes Treatment and KHC Should Invest in Pot
In this day and age, companies must be 'disruptors' or get left in the dust.
Peltz Is the Perfect Problem Solver for Aurora Cannabis
Peltz's addition should pacify a persistent critique of the company.
Key Takeaways
* The consensus is growing more consensus! * The notion of risk has left the Exchange's building * The last hour of trading uncharacteristically weak Today's session was another one supported by good overall breadth (2,154/786 on the NYSE). Howeve...
